Pharmalot… Pharmalittle… The Weekend Nears
Make a commentBy Ed Silverman // June 25th, 2010 // 6:32 am
And so another work week will soon draw to a close. Not a moment to soon, eh? Well, hopefully, your week has been productive and rewarding. Now, though, it is time to consider other activities. Have any interesting weekend plans? We hope to catch up on sundry chores, a bit of reading and promenade with the official Pharmalot mascots. Whatever you do, have an enjoyable time. See you soon…
Massachusetts May Repeal Ban On Gifts To Doctors (Boston Globe)
Merck Wins EMA Support For Antpsychotic (Reuters)
Sanofi Signs $375M Deal With Metabolex (PharmaTimes)
The Qnexa Diet Pill Goes To An FDA Panel (Minynaville)
Shire Gaucher Disease Drug Wins EMA Backing (Reuters)
Glaxo Explores ‘Printed’ Pill Technology (Dow Jones)
Novartis’ Gleevec Fails To Win UK Backing For GIST Patients (Bloomberg News)
Senate Bill Would Increase Medicaid Rebate From Drugmakers (The Hill)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Amylin Pharmaceuticals, Bydureon, Diabetes, Eli Lilly, Gaucher disease, Gifts, Gleevec, Lantus, Massachusetts, Medicaid, Merck, Metabolex, Novartis, Orexigen, Qnexa, Rebates, Sanofi Aventis, Shire Pharmaceuticals, Vivus